Utility of Gadolinium Use in the Imaging Follow-Up of Nonenhancing Primary Brain Neoplasms in Children

Background and purpose Gadolinium-based contrast agents (GBCAs) have been administered clinically since 1988. They are remarkably well tolerated by children and result in dose-dependent tissue deposition, even in patients with normal renal function. No adverse effects of gadolinium deposition in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhamber, Tiagpaul, Sarwar, Zereen, Jones, Yekaterina, Albers, Brittany K, Shah, Chetan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753578/
https://www.ncbi.nlm.nih.gov/pubmed/36532940
http://dx.doi.org/10.7759/cureus.31531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753578/
https://www.ncbi.nlm.nih.gov/pubmed/36532940
http://dx.doi.org/10.7759/cureus.31531

Ejemplares similares